AbbVie to Host Third-Quarter 2025 Earnings Conference Call
Rhea-AI Summary
AbbVie (NYSE:ABBV) has scheduled its third-quarter 2025 financial results announcement for Friday, October 31, 2025, before market opening. The company will conduct a live earnings conference call at 8 a.m. Central time.
Investors can access the webcast through AbbVie's Investor Relations website at investors.abbvie.com. An archived version of the presentation will be made available later the same day.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, ABBV declined 3.20%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: | Investors: |
Gabby Tarbert | Liz Shea |
(224) 244-0111 | (847) 935-2211 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-third-quarter-2025-earnings-conference-call-302571622.html
SOURCE AbbVie
